Stephen B Tatter, M.D. Ph.D.

Affiliations: 
1978-1982 BS Cellular & Molecular Biology University of Michigan, Ann Arbor, Ann Arbor, MI 
 1982-1989 PhD Virology Laboratory Rockefeller University, New York, NY, United States 
 1982-1990 MD Biomedical Science Weill Cornell Medical College, New York, NY, United States 
 1990-1997 Neurosurgery Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States 
 1997- Neurosurgery Wake Forest Atrium School of Medicine 
Area:
brain and pituitary tumors, image-guided neurosurgery, stereotactic radiosurgery, deep brain stimulation, trigeminal neuralgia, human brain catecholamine measurement
Website:
https://orcid.org/0000-0002-1063-0431
Google:
"Dr. Stephen B. Tatter"
Bio:

Primary laboratory and clinical research interest: image guidance to introduce therapeutic viruses, drugs, radiation, and devices into the human brain for treatment and study of brain and pituitary tumors, of movement disorders, trigeminal neuralgia, and of normal brain function related to reward-based learning, decision making, and attentional selection. Clinically busy neurosurgeon at the Wake Forest Baptist Medical Center in Winston-Salem, NC and Gamma Knife Co-director, Department of Neurosurgery, Wake Forest University School of Medicine.

Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sharma P, Sonawane P, Herpai D, et al. (2020) Multireceptor targeting of glioblastoma. Neuro-Oncology Advances. 2: vdaa107
Bang D, Kishida KT, Lohrenz T, et al. (2020) Sub-second Dopamine and Serotonin Signaling in Human Striatum during Perceptual Decision-Making. Neuron
Renfrow JJ, Soike MH, West JL, et al. (2020) Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor. Scientific Reports. 10: 15195
Rossmeisl JH, Herpai D, Quigley M, et al. (2020) Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas. Neuro-Oncology
Helis CA, Hughes RT, Cramer CK, et al. (2020) Stereotactic Radiosurgery for Atypical and Anaplastic Meningiomas. World Neurosurgery
Helis CA, Hughes RT, Glenn CW, et al. (2020) Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated with Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy. International Journal of Radiation Oncology, Biology, Physics
Vitek JL, Jain R, Chen L, et al. (2020) Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study. The Lancet. Neurology. 19: 491-501
Helis CA, Hughes RT, Munley MT, et al. (2020) Results of a third Gamma Knife radiosurgery for trigeminal neuralgia. Journal of Neurosurgery. 1-7
LeCompte MC, Hughes RT, Farris M, et al. (2020) Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery. Journal of Neuro-Oncology
Lanier CM, Hughes R, Ahmed T, et al. (2019) Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries. Neuro-Oncology Practice. 6: 402-409
See more...